Research Research Programs Biotechnology, Imaging & Drug Development Systems, Pathways & Targets Cancer Control Clinical Research Stern Center for Cancer Clinical Trials and Research Disease-Oriented Teams Protocol Review and Monitoring Committee Research Resources Membership Guidelines Shared Resources Acknowledgement of Grant and Shared Resources Anti-Cancer Challenge Research Anti-Cancer Challenge Pilot Awards Anti-Cancer Challenge Past Awardees Team Funds Centers & Institutes Space Management and Requests Funding Opportunities A1 Bridge Funding Cancer Health Disparity Research and Interventional Studies Membership Guidelines Home Research Research Resources Membership Guidelines Chao Family Comprehensive Cancer Center (CFCCC) membership is available to faculty or researchers with PI status at UCI or a non-UCI faculty member of another institution who is not a member of another NCI-designated Cancer Center and who has a substantial collaboration with a UCI Cancer Center member(s). Membership Application Procedure To apply for membership, please complete the online application and provide the required attachments. Each application will first be screened for eligibility by the CFCCC Administrative Unit before review by the respective Program Leaders and, subsequently, the Director for final approval. Incomplete applications will be returned for completion before review. The membership review process takes three to four weeks. Apply Now Who is eligible? To be considered, applicants must be eligible for principal investigator (PI) status on research proposals, have a predominant and productive interest in cancer or a related discipline, and be willing and able to contribute to CFCCC. What are the membership levels? Member A UCI faculty member or researcher with PI status meeting at least one of the following criteria: Has independent cancer-relevant peer-reviewed research funding or career development (e.g., K22) from a NCI-approved peer-review agency or organization Is a project leader on a qualifying multiproject research grant (e.g. P01, U54, SPORE) Is a clinical research leader as evidenced by having P.I. status on an interventional clinical trial or a peer-reviewed non-interventional trial Holds a Cancer Center leadership position (Deputy Director, Associate Directors, Program Leader, Shared Resource Directors, and Disease-Oriented Team Leaders) Is a key new cancer-relevant recruit to UCI and within the first three years of faculty appointment (e.g., junior faculty) Associate Member A UCI faculty member or researcher (including those with P.I. status), or a faculty member of another institution who is not a member of another NCI-designated cancer center and who has a substantial collaboration with a CFCCC member(s), meeting at least one of the following criteria: Contributes in a substantial way to cancer-related research, patient care, education, or community service but does not qualify as a Member A non-UCI clinician or researcher who is not a member of another NCI-designated cancer center and who has a substantial collaboration with a UCI Cancer Center member(s) What three Research Programs can I choose from? Biotechnology, Imaging & Drug Development The broad goal is to utilize novel computational, chemical, and engineering-based approaches to detect, diagnose, and treat cancer. Learn More Systems, Pathways & Targets The broad goal of is to discover new aspects of cancer biology that can be exploited for the development of novel treatments and diagnostics. Learn More Cancer Control The broad goal is to foster and facilitate research designed to identify and reduce cancer risk, and to improve cancer outcomes throughout the disease continuum. Learn More Membership Benefits All categories of members are provided regular information, primarily through CFCCC Bulletins from Constant Contact, about Center research activities, symposia, education and outreach, and other activities in furtherance of the Cancer Center mission. All categories of members, in addition, receive many benefits like the following: Priority access and subsidy to CFCCC Shared Resources Publication rebate for acknowledgement of Shared Resources Ability to apply to intramural funds provided by the Cancer Center including pilot project and bridge funding Pre-award support for clinical trial contracts through the Sue and Ralph Stern Center for Cancer Clinical Trials & Research (Stern Center) Integration into one or more of the Disease-Oriented Teams (DOTs) responsible for feasibility review and approval of all clinical research Administrative pre- and post-award management of major, collaborative funding proposals characterized by substantial, multidisciplinary participation of researchers Membership Responsibilities As part of the cancer research community, the benefits received by Members entail certain responsibilities, namely to acknowledge the Cancer Center Support Grant and/or Shared Resources as appropriate in your publication or grant. For more information or to ask any questions, please contact CFCCC Administration at cfcccadmin@hs.uci.edu. CCSG Acknowledgement “Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under award number P30CA062203. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.” Shared Resources Acknowledgement “The authors wish to acknowledge the support of the Chao Family Comprehensive Cancer Center <SHARED RESOURCE NAME> Shared Resource, supported by the National Cancer Institute of the National Institutes of Health under award number P30CA062203. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.”